首页 | 官方网站   微博 | 高级检索  
     

颈动脉支架置入术与内膜切除术治疗颈动脉狭窄的远期转归比较:随机对照试验的汇总分析
引用本文:张鹏飞,郭艳婷,赵文可,赵立文,汪子文,何一川,于耀宇.颈动脉支架置入术与内膜切除术治疗颈动脉狭窄的远期转归比较:随机对照试验的汇总分析[J].国际脑血管病杂志,2017,25(4).
作者姓名:张鹏飞  郭艳婷  赵文可  赵立文  汪子文  何一川  于耀宇
作者单位:1. 300162 天津,武警后勤学院附属医院神经外科;121000 锦州医科大学研究生学院;2. 武警后勤学院附属医院神经外科, 天津,300162
摘    要:目的 通过汇总分析评价颈动脉内膜切除术(carotid endarterectomy, CEA)与颈动脉支架置入术(carotid artery stenting, CAS)治疗颈动脉狭窄的远期转归.方法 检索PubMed、EMBASE和Cochrane数据库,纳入在颈动脉狭窄患者中比较CEA与CAS治疗的随机对照试验,提取研究基本特征以及远期转归,包括卒中或死亡联合终点、任何卒中、任何死亡等数据,应用Stata软件进行统计分析.结果 共纳入7项随机对照试验和8 210例患者,随访时间中位数为2~7.4年.纳入研究的质量整体较高,产生偏倚的风险较低.汇总分析显示,CAS组卒中或死亡联合终点风险比(hazard risk, HR) 1.21,95% CI 1.04~1.39]、任何卒中(HR 1.32,95% CI 1.15~1.51)和同侧卒中(HR 1.26,95% CI 1.02~1.55)风险显著高于CEA组;CAS组死亡(HR 1.06,95% CI 0.95~1.18)、致残性卒中(HR 1.23,95% CI 0.95~1.60)、非同侧卒中(HR 1.12,95% CI 0.81~1.55)和再狭窄(HR 1.18,95% CI 0.91~1.52)风险均与CEA组无显著性差异,但.结论 CAS在远期死亡、致残性卒中、非同侧卒中和再狭窄风险方面与CEA相近,但CAS的远期卒中或死亡联合终点、任何卒中和同侧卒中风险显著更高.这些结果提示,CEA仍是颈动脉狭窄的治疗选择.

关 键 词:颈动脉狭窄  颈动脉内膜切除术  支架  随机对照试验专题  卒中  时间因素  治疗结果  Meta分析

Long-term outcomes of carotid artery stenting versus endarterectomy for carotid stenosis: A meta-analysis of randomized controlled trials
Zhang Pengfei,Guo Yanting,Zhao Wenke,Zhao Liwen,Wang Ziwen,He Yichuan,Yu Yaoyu.Long-term outcomes of carotid artery stenting versus endarterectomy for carotid stenosis: A meta-analysis of randomized controlled trials[J].International Journal of Cerebrovascular Diseases,2017,25(4).
Authors:Zhang Pengfei  Guo Yanting  Zhao Wenke  Zhao Liwen  Wang Ziwen  He Yichuan  Yu Yaoyu
Abstract:ObjectiveTo evaluate the long-term outcomes of carotid endarterectomy versus carotid artery stenting for carotid stenosis.MethodsPubMed, EMBASE, and the Cochrane databases were retrieved.The randomized controlled trials of comparing CEA with CAS in patients with carotid artery stenosis were enrolled.The data such as the research basic characteristics and the long-term outcomes including stroke or death combined endpoints, any stroke or any death were extracted.The Stata software was used to conduct statistical analysis.ResultsA total of 7 randomized controlled trials and 8 210 patients were included.The median follow-up time was 2-7.4 years.The overall quality of the included studies was high and the risk of bias was low.The meta-analysis showed that the risks of the combined endpoint of stroke or death (hazard risk HR] 1.21, 95% confidence interval CI] 1.04-1.39), any stroke (HR 1.32, 95% CI 1.15-1.51) and ipsilateral stroke (HR 1.26, 95% CI 1.02-1.55) in the CAS group were significantly higher than those in the CEA group;the risks of death (HR 1.06, 95% CI 0.95-1.18), disabling stroke (HR 1.23, 95% CI 0.95-1.60), non-ipsilateral stroke (HR 1.12,95% CI 0.81-1.55) and restenosis (HR 1.18,95% CI 0.91-1.52) were not significantly different between between the CAS group and the CEA group.Conclusions CAS and CEA are associated with similar risks of long-term death, disabling stroke, non-ipsilateral stroke and restenosis.The risks of long-term combined endpoint of stroke or death, any stroke and ipsilateral stroke significantly higher with CAS.These results suggest that CEA remains the treatment of choice for carotid stenosis.
Keywords:Carotid Stenosis  Endarterectomy  Carotid  Stents  Randomized Controlled Trials as Topic  Stroke  Time Factors  Treatment Outcome  Meta-Analysis
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号